Inhaled corticosteroid
This page covers all Inhaled corticosteroid drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Glucocorticoid receptor, Glucocorticoid receptors, glucocorticoid receptor.
Targets
Glucocorticoid receptor · Glucocorticoid receptors · glucocorticoid receptor
Marketed (26)
- Budesonide, Beclomethasone, Fluticasone · West Penn Allegheny Health System · Respiratory/Pulmonology
These inhaled corticosteroids reduce airway inflammation by binding to glucocorticoid receptors and suppressing inflammatory cytokine production. - Nebulized beclomethasone dipropionate · Istituto per la Ricerca e l'Innovazione Biomedica · Respiratory
Beclomethasone dipropionate is a corticosteroid that suppresses airway inflammation by binding to glucocorticoid receptors and reducing inflammatory mediator production. - Fluticasone MDI · University of North Carolina, Chapel Hill · Respiratory/Pulmonology
Fluticasone is a corticosteroid that reduces inflammation in the airways by binding to glucocorticoid receptors and suppressing inflammatory mediator release. - Budesonide 200 microgram/Puff, HFA MDI · Intech Biopharm Ltd. · Respiratory
Budesonide is a corticosteroid that reduces inflammation in the airways by binding to glucocorticoid receptors and suppressing inflammatory mediator release. - Fluticasone Propionate (FP) · Dey · Respiratory / Pulmonology
Fluticasone propionate is a corticosteroid that binds to glucocorticoid receptors in the cytoplasm, translocates to the nucleus, and suppresses inflammatory gene transcription to reduce airway inflammation. - Fluticasone Furoate (FF) · GlaxoSmithKline · Respiratory / Pulmonology
Fluticasone furoate is a corticosteroid that binds to glucocorticoid receptors in the lungs to reduce inflammation and suppress immune responses in respiratory tissues. - Mometasone furoate 440 · California Allergy and Asthma Medical Group, Inc. · Respiratory / Allergy / Immunology
Mometasone furoate is a corticosteroid that reduces inflammation by binding to glucocorticoid receptors and suppressing inflammatory mediator production. - Beclomethasone (QVAR) · University Medical Center Groningen · Respiratory/Pulmonology
Beclomethasone is an inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors and suppressing inflammatory mediator production. - Beclomethasone, Fluticasone, Budesonide · West Penn Allegheny Health System · Respiratory/Pulmonology
These inhaled corticosteroids reduce airway inflammation by binding to glucocorticoid receptors and suppressing inflammatory cytokine production. - preoperative budesonide inhalation · Fujian Medical University Union Hospital · Respiratory
Budesonide is an inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors and suppressing inflammatory mediator production. - Fluticasone Evohaler pMDI · University of Dundee · Respiratory
Fluticasone propionate is a corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors and suppressing inflammatory mediator release. - Qvar · Teva Branded Pharmaceutical Products R&D, Inc. · Respiratory/Pulmonology
Qvar is an inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in lung tissue. - Budesonide inhalation suspension · AstraZeneca · Respiratory/Pulmonology
Budesonide is a corticosteroid that reduces inflammation in the airways by binding to glucocorticoid receptors and suppressing inflammatory mediator production. - Fluticasone Propionate_6 · Imperial College London · Respiratory/Pulmonology
Fluticasone propionate is a corticosteroid that suppresses inflammatory and immune responses by binding to glucocorticoid receptors in target tissues. - Pulmicort (budesonide) pMDI · AstraZeneca · Respiratory / Pulmonology
Budesonide is a corticosteroid that binds to glucocorticoid receptors in the lungs to reduce inflammation and suppress immune responses in the airways. - Fluticasone, Budesonide, Beclomethasone · West Penn Allegheny Health System · Respiratory / Pulmonology
These inhaled corticosteroids reduce airway inflammation by binding to glucocorticoid receptors and suppressing inflammatory cytokine production. - Beclomethasone dipropionate HFA · National Jewish Health · Respiratory/Pulmonology
Beclomethasone dipropionate is a corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors and suppressing inflammatory mediator release. - HFA FP MDI · University of Florida · Respiratory
HFA FP MDI is a hydrofluoroalkane-propelled metered-dose inhaler delivering fluticasone propionate, a corticosteroid that reduces airway inflammation by binding glucocorticoid receptors. - beclomethasone HFA · Milton S. Hershey Medical Center · Respiratory
Beclomethasone is a corticosteroid that reduces inflammation in the airways by suppressing immune cell activity and inflammatory mediator release. - Fluticasone Evohaler · University of Dundee · Respiratory
Fluticasone is a corticosteroid that reduces inflammation in the airways by binding to glucocorticoid receptors and suppressing inflammatory mediator release. - Beclomethasone (Clenil) · University Medical Center Groningen · Respiratory
Beclomethasone is a corticosteroid that suppresses inflammatory and immune responses by binding to glucocorticoid receptors in the lungs. - Budesonide (Pulmicort) · University of Nottingham · Respiratory/Pulmonology
Budesonide is a corticosteroid that binds to glucocorticoid receptors in the lungs to suppress inflammatory responses and reduce airway inflammation. - MDI FP · Imperial College London · Respiratory / Pulmonology
MDI FP is a metered-dose inhaler formulation of fluticasone propionate that delivers corticosteroid directly to the airways to reduce inflammation and airway obstruction. - fluticasone propionate hydrofluoroalkane (HFA) · Organon and Co · Immunology
Fluticasone propionate HFA is a potent inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors. - placebo, isotonic ciclesonide, hypotonic ciclesonide · University of Chicago · Respiratory / Pulmonology
Ciclesonide is an inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in the lungs. - Placebo to budesonide inhaler · Organon and Co · Respiratory/Pulmonology
Budesonide is a corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors and suppressing inflammatory cytokine production.
Phase 3 pipeline (26)
- Comparator: fluticasone · Merck Sharp & Dohme LLC · Respiratory / Pulmonology
Fluticasone is a corticosteroid that reduces inflammation by binding to glucocorticoid receptors and suppressing immune cell activation and inflammatory mediator release. - FF Inhalation Powder · GlaxoSmithKline · Respiratory / Pulmonology
FF (fluticasone furoate) is an inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in lung tissue. - Beclomethasone Dipropionate 640 · Teva Branded Pharmaceutical Products R&D, Inc. · Respiratory
Beclomethasone dipropionate is a corticosteroid that suppresses inflammatory and immune responses by binding to glucocorticoid receptors in the lungs. - Budesonide HFA · AstraZeneca · Respiratory/Pulmonology
Budesonide is a corticosteroid that reduces inflammation in the airways by binding to glucocorticoid receptors and suppressing inflammatory mediator production. - Pulmicort Turbuhaler · AstraZeneca · Respiratory / Pulmonology
Pulmicort (budesonide) is an inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in lung tissue. - Beclomethasone dipropionate breath-actuated inhaler · Teva Branded Pharmaceutical Products R&D, Inc. · Respiratory/Pulmonology
Beclomethasone dipropionate is a corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors and suppressing inflammatory mediator release. - BDP · Teva Branded Pharmaceutical Products R&D, Inc. · Respiratory / Pulmonology
BDP is a inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in the lungs. - Beclomethasone dipropionate BAI · Teva Branded Pharmaceutical Products R&D, Inc. · Respiratory / Immunology
Beclomethasone dipropionate is a corticosteroid that suppresses inflammatory and immune responses by binding to glucocorticoid receptors in target tissues. - BDP DPI 2 months · Chiesi Farmaceutici S.p.A. · Respiratory / Pulmonology
BDP (beclomethasone dipropionate) is an inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in the lungs. - Flixotide pMDI 250 micrograms · Mundipharma Research Limited · Respiratory / Pulmonology
Fluticasone propionate is an inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in the lungs. - Budesonide CFC · AstraZeneca · Respiratory/Pulmonology
Budesonide is a corticosteroid that suppresses inflammatory and immune responses by binding to glucocorticoid receptors in the lungs. - Budesonide HFA pMDI · AstraZeneca · Respiratory/Pulmonology
Budesonide is a corticosteroid that reduces inflammation in the airways by binding to glucocorticoid receptors and suppressing inflammatory mediator production. - Fluticasone Furoate Inhalation Powder · GlaxoSmithKline · Respiratory / Pulmonology
Fluticasone furoate is a corticosteroid that binds to glucocorticoid receptors in the lungs to reduce inflammation and suppress immune responses in the airways. - Symbicort pMDI + budesonide HFA pMDI · AstraZeneca · Respiratory / Pulmonology
Budesonide is an inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in the lungs. - Fluticasone Discus 250 µg · AstraZeneca · Respiratory
Fluticasone propionate is a corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors and suppressing inflammatory mediator release. - SKP-Fluticasone · SkyePharma AG · Respiratory / Pulmonology
SKP-Fluticasone is a corticosteroid that reduces inflammation by binding to glucocorticoid receptors and suppressing immune and inflammatory responses. - Fluticasone propionate 100 · SkyePharma AG · Respiratory / Pulmonology
Fluticasone propionate is a corticosteroid that suppresses inflammatory and immune responses by binding to glucocorticoid receptors in target tissues. - Flovent Fluticasone HFA · SkyePharma AG · Respiratory / Pulmonology
Fluticasone propionate is an inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors and suppressing inflammatory mediator production. - BDP HFA 100 µg pMDI · Chiesi Farmaceutici S.p.A. · Respiratory / Pulmonology
BDP (beclomethasone dipropionate) is an inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in the lungs. - Beclomethasone (BDP) · Chiesi Farmaceutici S.p.A. · Respiratory / Pulmonology
Beclomethasone is a corticosteroid that suppresses inflammatory and immune responses by binding to glucocorticoid receptors in the lungs. - FF via ELLIPTA DPI · GlaxoSmithKline · Respiratory / Pulmonology
FF (fluticasone furoate) is an inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in the lungs. - Ciclesonide (XRP1526) · Sanofi · Respiratory / Pulmonology
Ciclesonide is an inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in lung tissue. - BDP HFA · Teva Branded Pharmaceutical Products R&D, Inc. · Respiratory / Pulmonology
BDP HFA is a inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in the lungs. - Budesonide pMDI · AstraZeneca · Respiratory / Pulmonology
Budesonide is a corticosteroid that reduces inflammation in the airways by binding to glucocorticoid receptors and suppressing inflammatory mediator production. - SAL056 (56.5μg) · Shenzhen Salubris Pharmaceuticals Co., Ltd. · Respiratory / Pulmonology
SAL056 is an inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in lung tissue. - Budesonide Turbuhaler 200 µg · AstraZeneca · Respiratory
Budesonide is a corticosteroid that reduces inflammation in the airways by binding to glucocorticoid receptors and suppressing inflammatory mediator production.
Phase 2 pipeline (3)
- Higher-dose inhaled corticosteroids · GlaxoSmithKline · Respiratory / Pulmonology
Higher-dose inhaled corticosteroids reduce airway inflammation by binding to glucocorticoid receptors in lung tissue, suppressing inflammatory cytokine production and immune cell activation. - Ciclesonide HFA · AstraZeneca · Respiratory
Ciclesonide is a prodrug that is converted to its active metabolite, des-ciclesonide, which binds to glucocorticoid receptors in the cytoplasm, leading to anti-inflammatory effects. - Chlorofluorocarbon beclomethasone dipropionate · Research in Real-Life Ltd · Respiratory / Pulmonology
Beclomethasone dipropionate is a corticosteroid that suppresses inflammatory and immune responses by binding to glucocorticoid receptors in the lungs.